NYSTATIN OINTMENT USP

Manufacturer
Preferred Pharmaceuticals, Inc.
Effective date
2022-09-15
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
8
Source
legacy-cache
Hydrated at
2026-08-01 21:53:35

Label at a glance#

ProductNystatin
Active ingredientNYSTATIN
Label structure10 sections

Indications and uses

Nystatin Ointment USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida [Monilia] albicans and other Candida species.

Dosage and administration

Nystatin Ointment USP should be applied liberally to affected areas twice a day or as indicated until healing is complete. Nystatin cream is usually preferred to nystatin ointment in candidiasis involving intertriginous areas; very moist lesions, however, are best treated with nystatin topical powder. This preparation does not stain skin or mucous membranes and provides a simple, convenient means of treatment.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

For Dermatologic Use Only

Not For Ophthalmic Use

Rx Only

DESCRIPTION

DESCRIPTION SECTION

Nystatin Ointment USP for topical use only, contains 100,000 USP Nystatin units per gram, in an ointment base of light mineral oil and white petrolatum. The structural formula is as follows:

structural formula
structural formula

Molecular Weight 926.13

Molecular Formula C47H75NO17

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Nystatin is an antifungal antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It probably acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin is a polyene antibiotic that is obtained from Streptomyces noursei, and is the first well tolerated antifungal antibiotic of dependable efficacy for the treatment of cutaneous, oral and intestinal infections caused by Candida [Monilia]albicans and other Candida species. It exhibits no appreciable activity against bacteria.

Nystatin Ointment USP provides specific therapy for all localized forms of candidiasis. Symptomatic relief is rapid, often occurring within 24 to 72 hours after the initiation of treatment. Cure is effected both clinically and mycologically in most cases of localized candidiasis.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Nystatin Ointment USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida [Monilia]albicans and other Candida species.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Nystatin Ointment USP is contraindicated in patients with a history of hypersensitivity to any of its components.

PRECAUTIONS

PRECAUTIONS SECTION

Should a reaction of hypersensitivity occur, the drug should be immediately withdrawn and appropriate measures taken.

This preparation is not for ophthalmic use.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Nystatin Ointment USP is virtually non-toxic and nonsensitizing and is well tolerated by all age groups including debilitated infants, even on prolonged administration. If irritation on topical application should occur, discontinue medication.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Nystatin Ointment USP should be applied liberally to affected areas twice a day or as indicated until healing is complete. Nystatin cream is usually preferred to nystatin ointment in candidiasis involving intertriginous areas; very moist lesions, however, are best treated with nystatin topical powder.

This preparation does not stain skin or mucous membranes and provides a simple, convenient means of treatment.

HOW SUPPLIED

HOW SUPPLIED SECTION

Nystatin Ointment USP (100,000 USP Nystatin Units per gram) is a yellow ointment available as follows:

15 g tube (NDC 68788-9516-1)

30 g tube (NDC 68788-9516-3)

STORAGE

STORAGE AND HANDLING SECTION

Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature].

Manufactured By Perrigo

Bronx, NY 10457

Distributed By

Perrigo®

Allegan, MI 49010 • www.perrigo.com

Rev 08-15

: 2K800 RC JX1

Relabeled By: Preferred Pharmaceuticals Inc.

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Rx Only

Nystatin Ointment USP

(100,000 USP Nystatin Units)

NET WT 15g or 30g

Nystatin Ointment USP (100,000 USP Nystatin Units
Nystatin Ointment USP (100,000 USP Nystatin Units

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
45802-048-11GM - Gram45802-0481ee4e49b-b21e-4d04-a4c2-3f7e3d82747b12012-07-24
45802-048-35GM - Gram45802-0487b60fa1f-03d4-4706-a26f-6c900db3cad812012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
NYSTATINACTIVE INGREDIENTBDF1O1C72E2
NYSTATINACTIVE MOIETYBDF1O1C72E2
LIGHT MINERAL OILINACTIVE INGREDIENTN6K5787QVP2
PETROLATUMINACTIVE INGREDIENT4T6H12BN9U2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68788-951668788-9516-1, 68788-9516-3
45802-048

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
NYSTATINBDF1O1C72EACTIB
LIGHT MINERAL OILN6K5787QVPIACT
PETROLATUM4T6H12BN9UIACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 2 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / TOPICAL7275 mgExact identifier — unii+route+dosage form
LIGHT MINERAL OILLIGHT MINERAL OILN6K5787QVPOINTMENT / TOPICAL1335 mgExact identifier — unii+route+dosage form

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062472-001NYSTATINNYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A062472-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-1384e616aacf4f…
2026-08-18 06:07:402026-07A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-132680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-135bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-1379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-131e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-138072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-135c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-135d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-134b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-1374a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-1387673890dc5c…
2021-03-12 10:30 UTC2021-03A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-135aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-138869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-133f01610625f2…
2019-09-15 20:21 UTC2019-09A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13b00525d2431f…
2019-07-19 19:46 UTC2019-07A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-136a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-131c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-139b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-133f0d92c62455…
2023-05-13 08:27 UTC2023-05A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13053a50430f4f…
2023-01-26 05:58 UTC2023-01A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-133bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-133a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A062472-001NYSTATIN100,000 UNITS/GMOINTMENT / TOPICALAT1984-02-13f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A062472-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A062472-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062472-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062472-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A062472-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062472-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062472-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062472-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062472-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062472-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062472-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062472-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062472-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062472-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062472-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062472-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062472-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062472-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062472-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062472-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062472-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062472-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062472-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A062472-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062472-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062472-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062472-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A062472-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A062472-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062472-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062472-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062472-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062472-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062472-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062472-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062472-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A062472-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A062472-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A062472-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A062472-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NystatinNYSTATINPadagis Israel Pharmaceuticals Ltd6c091c66-2e4d-4412-b7bf-35315dc8152f2025-01-23Adverse reactionsExact identifier
ndc (product): 45802-048
e088da32-b172-4f29-b76b-a02e70bf2623d00a5f80-aa50-4b0b-82d2-63ba33a56b2f2023-08-16Adverse reactionsExact identifier
spl set id: d00a5f80-aa50-4b0b-82d2-63ba33a56b2f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.